NTLA-3001 in Adults with Alpha-1 Antitrypsin Deficiency-Associated Lung Disease

Stopped Clinical trial ITL-3001-CL-101 for the investigational product NTLA-3001 was withdrawn due to prioritization of other Sponsor programs.

Conditions

• Lung Disease
• Pulmonary Disease
• AATD
• Alpha-1 Antitrypsin Deficiency
• Alpha-1 Antitrypsin Deficiency-associated Lung Disease

Interventions

• BIOLOGICAL: Biological NTLA-3001

Sponsor

Intellia Therapeutics